FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Mak

Research Profile

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Sujana S Gunta; Robert H Mak
Ghrelin and leptin pathophysiology in chronic kidney disease.
Robert H Mak; Bradley A Warady
Dialysis: Vascular access in children--arteriovenous fistula or CVC?
Wai W Cheung; Robert H Mak
Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Mak (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sujana S Gunta; Robert H Mak
Ghrelin and leptin pathophysiology in chronic kidney disease.
Pediatric nephrology (Berlin, Germany) 2013;28(4):611-6.
2013: Robert H Mak; Bradley A Warady
Dialysis: Vascular access in children--arteriovenous fistula or CVC?
Nature reviews. Nephrology 2013;9(1):9-11.
2012: Wai W Cheung; Robert H Mak
Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.
American journal of physiology. Renal physiology 2012;303(9):F1315-24.
2012: Bethany J Foster; Lynn McCauley; Robert H Mak
Nutrition in infants and very young children with chronic kidney disease.
Pediatric nephrology (Berlin, Germany) 2012;27(9):1427-39.
2012: Robert H Mak; Wai W Cheung
MicroRNAs: a new therapeutic frontier for muscle wasting in chronic kidney disease.
Kidney international 2012;82(4):373-4.
2011: Robert H Mak
Serum myostatin in patients on maintenance haemodialysis: a useful biomarker of muscle wasting?.
Clinical endocrinology 2011;75(6):738-9.
2011: Wai W Cheung; Kyung Hoon Paik; Jian-Ying Zhan; Robert H Mak
The impact of inflammation on bone mass in children.
Pediatric nephrology (Berlin, Germany) 2011;26(11):1937-46.
2011: Susan L Furth; Judith Jerry-Fluker; Frederick J Kaskel; Robert H Mak; Marva Moxey-Mims; George J Schwartz; ALISON ABRAHAM; Mark Benfield; Craig Wong; Bradley A Warady
Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(9):2132-40.
2011: Robert H Mak; Dominic S Raj; Peter Stenvinkel; T Alp Ikizler; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Erratum to: Wasting in chronic kidney disease.
Journal of cachexia, sarcopenia and muscle 2011;2(2):119.
2011: Robert H Mak; Wai W Cheung
Is ghrelin a biomarker for mortality in end-stage renal disease?
Kidney international 2011;79(7):697-9.
2010: Wai W Cheung; Kyung Hoon Paik; Robert H Mak
Inflammation and cachexia in chronic kidney disease.
Pediatric nephrology (Berlin, Germany) 2010;25(4):711-24.
2010: Robert H Mak; George Bakris
Pediatrics: Masked hypertension: a risk factor in children with CKD.
Nature reviews. Nephrology 2010;6(3):132-4.
2010: Wai W Cheung; Robert H Mak
Ghrelin in chronic kidney disease.
International journal of peptides 2010;2010():.
2009: Wai W Cheung; Robert H Mak
Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease.
Kidney international 2009;76(2):135-7.
2009: Craig S Wong; Christopher B Pierce; Stephen R Cole; Bradley A Warady; Robert H Mak; Nadine M Benador; Frederick J Kaskel; Susan L Furth; George J Schwartz
Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(4):812-9.
2009: George J Schwartz; ALVARO MUNOZ; Michael F Schneider; Robert H Mak; Frederick J Kaskel; Bradley A Warady; Susan L Furth
New equations to estimate GFR in children with CKD.
Journal of the American Society of Nephrology : JASN 2009;20(3):629-37.
2009: Robert H Mak
Recent advances in chronic dialysis and renal transplantation in children.
Pediatric nephrology (Berlin, Germany) 2009;24(3):459-61.
2008: Robert H Mak
Acute kidney injury in children: the dawn of a new era.
Pediatric nephrology (Berlin, Germany) 2008;23(12):2147-9.
2008: Wai W Cheung; Sanna Rosengren; David L Boyle; Robert H Mak
Modulation of melanocortin signaling ameliorates uremic cachexia.
Kidney international 2008;74(2):180-6.
2008: Robert H Mak
Insulin and its role in chronic kidney disease.
Pediatric nephrology (Berlin, Germany) 2008;23(3):355-62.
2008: Robert H Mak; Wai W Cheung; Charles T Roberts
The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2008;18(1):17-25.
2008: Robert H Mak; Joanne H Wong
Are oral antibiotics alone efficacious for the treatment of a first episode of acute pyelonephritis in children?
Nature clinical practice. Nephrology 2008;4(1):10-1.
2007: Robert H Mak; Wai Cheung
Therapeutic strategy for cachexia in chronic kidney disease.
Current opinion in nephrology and hypertension 2007;16(6):542-6.
2007: Robert H Mak
Chronic kidney disease in children: state of the art.
Pediatric nephrology (Berlin, Germany) 2007;22(10):1687-8.
2007: Wai W Cheung; Huey-Ju Kuo; Stacy Markison; Chen Chen; Alan C Foster; Daniel L Marks; Robert H Mak
Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice.
Journal of the American Society of Nephrology : JASN 2007;18(9):2517-24.
2007: Robert H Mak; Wai Cheung
Adipokines and gut hormones in end-stage renal disease.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2007;27 Suppl 2():S298-302.
2007: Ihab M Wahba; Robert H Mak
Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(3):550-62.
2007: Robert H Mak; Wai Cheung; Jonathan Q Purnell
Ghrelin in chronic kidney disease: too much or too little?
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2007;27(1):51-5.
2007: Robert H Mak; Wai Cheung
Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling.
Current opinion in nephrology and hypertension 2007;16(1):27-31.
2007: Robert H Mak; Willem Proesmans; Howard Trachtman
Teaching articles: a new goal of the journal.
Pediatric nephrology (Berlin, Germany) 2007;22(1):24-5.
2006: Robert H Mak; Wai Cheung
Energy homeostasis and cachexia in chronic kidney disease.
Pediatric nephrology (Berlin, Germany) 2006;21(12):1807-14.
2006: Robert H Mak
Can plasma iohexol disappearance be used to measure GFR in children with chronic kidney disease?
Nature clinical practice. Nephrology 2006;2(11):608-9.
2006: Robert H Mak; Huey-Ju Kuo; Wai W Cheung
Animal models of obesity-associated chronic kidney disease.
Advances in chronic kidney disease 2006;13(4):374-85.
2006: Susan L Furth; Stephen R Cole; Marva Moxey-Mims; Frederick J Kaskel; Robert H Mak; George Schwartz; Craig Wong; ALVARO MUNOZ; Bradley A Warady
Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(5):1006-15.
2006: Robert H Mak; Wai Cheung; Roger D Cone; Daniel L Marks
Mechanisms of disease: Cytokine and adipokine signaling in uremic cachexia.
Nature clinical practice. Nephrology 2006;2(9):527-34.
2006: Robert H Mak; Peter Rotwein
Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation.
Kidney international 2006;70(3):410-2.
2006: Robert H Mak; Huey-Ju Kuo
Pathogenesis of urinary tract infection: an update.
Current opinion in pediatrics 2006;18(2):148-52.
2006: Robert H Mak; Wai Cheung; Roger D Cone; Daniel L Marks
Leptin and inflammation-associated cachexia in chronic kidney disease.
Kidney international 2006;69(5):794-7.
2005: Wai Cheung; Pin X Yu; Brian M Little; Roger D Cone; Daniel L Marks; Robert H Mak
Role of leptin and melanocortin signaling in uremia-associated cachexia.
The Journal of clinical investigation 2005;115(6):1659-65.
2005: Robert H Mak; Wai Cheung; Roger D Cone; Daniel L Marks
Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease.
Pediatric nephrology (Berlin, Germany) 2005;20(3):427-31.
2004: Robert H Mak; Stella L Chang; Aparna Draksharapu; Youngmi Kim Pak
Gene expression in uremic left ventricular hypertrophy: effects of hypertension and anemia.
Experimental & molecular medicine 2004;36(3):251-8.
2004: Robert H Mak; Stella L Chang; Youngmi Kim Pak
Growth impairment of primary chondrocyte cells by serum of rats with chronic renal failure.
Experimental & molecular medicine 2004;36(3):243-50.
2003: Robert H Mak; Huey-Ju Kuo
Primary ureteral reflux: emerging insights from molecular and genetic studies.
Current opinion in pediatrics 2003;15(2):181-5.
2000: Robert H Mak
Impact of end-stage renal disease and dialysis on glycemic control.
Seminars in dialysis 2000;13(1):4-8.
1999: Robert H Mak
Effect of metabolic acidosis on hyperlipidemia in uremia.
Pediatric nephrology (Berlin, Germany) 1999;13(9):891-3.
1999: Robert H Mak
Effect of metabolic acidosis on branched-chain amino acids in uremia.
Pediatric nephrology (Berlin, Germany) 1999;13(4):319-22.
1998: Robert H Mak
Metabolic effects of erythropoietin in patients on peritoneal dialysis.
Pediatric nephrology (Berlin, Germany) 1998;12(8):660-5.
1998: Robert H Mak
Insulin, branched-chain amino acids, and growth failure in uremia.
Pediatric nephrology (Berlin, Germany) 1998;12(8):637-42.
1998: Robert H Mak
Effect of metabolic acidosis on insulin action and secretion in uremia.
Kidney international 1998;54(2):603-7.
1998: Robert H Mak
1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia.
Kidney international 1998;53(5):1353-7.
1997: Edward J Alfrey; Oscar Salvatierra; DC Tanney; Robert H Mak; John D Scandling; Donald C Dafoe; Gregory B Hammer; Pamela Orlandi; L Page; SB Conley
Bladder augmentation can be problematic with renal failure and transplantation.
Pediatric nephrology (Berlin, Germany) 1997;11(6):672-5.
1997: Oscar Salvatierra; Edward J Alfrey; DC Tanney; Robert H Mak; Gregory B Hammer; Elliot J Krane; Samuel K S So; KV Lemley; Pamela Orlandi; S B Conley
Superior outcomes in pediatric renal transplantation.
Archives of surgery (Chicago, Ill. : 1960) 1997;132(8):842-7; discussion 847-9.
1997: Edward J Alfrey; SB Conley; DC Tanney; Robert H Mak; John D Scandling; Donald C Dafoe; Gregory B Hammer; Pamela Orlandi; L Page; Oscar Salvatierra
Use of an augmented urinary bladder can be catastrophic in renal transplantation.
Transplantation proceedings 1997;29(1-2):154-5.
1996: Robert H Mak; Y K Pak
End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure.
Kidney international 1996;50(2):400-6.
1996: Robert H Mak
Insulin resistance in uremia: effect of dialysis modality.
Pediatric research 1996;40(2):304-8.
1996: Robert H Mak; O Mehls
Insulin-like growth factor-I action on glucose transport in acute renal failure.
The American journal of physiology 1996;271(2 Pt 2):F440-5.
1996: Robert H Mak
Insulin resistance but IGF-I sensitivity in chronic renal failure.
The American journal of physiology 1996;271(1 Pt 2):F114-9.
1996: Robert H Mak
Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia.
The Journal of pediatrics 1996;129(1):97-104.
1996: Robert H Mak
Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia.
The American journal of physiology 1996;270(5 Pt 2):F839-44.
1995: Robert H Mak
Insulin secretion and growth failure in uremia.
Pediatric research 1995;38(3):379-83.
1994: Robert H Mak; George B Haycock; C Chantler
Insulin and growth in chronic renal failure.
Pediatric nephrology (Berlin, Germany) 1994;8(3):309-12.
1993: Robert H Mak
Early history of renal rickets.
American journal of nephrology 1993;13(4):293-7.
1992: Robert H Mak
Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients.
Pediatric nephrology (Berlin, Germany) 1992;6(4):345-8.
1992: Robert H Mak
Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.
Kidney international 1992;41(4):1049-54.
1992: Robert H Mak; Ralph DeFronzo
Glucose and insulin metabolism in uremia.
Nephron 1992;61(4):377-82.
1992: Robert H Mak; J H Wong
The vitamin D/parathyroid hormone axis in the pathogenesis of hypertension and insulin resistance in uremia.
Mineral and electrolyte metabolism 1992;18(2-5):156-9.
1991: R M Karpati; Robert H Mak; K V Lemley
Hypercalcemia, hypertension and acute renal insufficiency in an immobilized adolescent.
Child nephrology and urology 1991;11(4):215-9.
1990: J C Buckland-Wright; M W Spring; Robert H Mak; C Turner; Juliet E Compston; Shobna Vedi; George B Haycock; C Chantler
Quantitative microfocal radiography of children with renal osteodystrophy; comparison with laboratory and histological findings.
The British journal of radiology 1990;63(752):609-14.
1990: A L Friedman; J D Heiliczer; C M Gundberg; Robert H Mak; Frank G Boineau; P T McEnery; J C Chan
Serum osteocalcin concentrations in children with chronic renal insufficiency who are not undergoing dialysis. Growth Failure in Children with Renal Diseases Study.
The Journal of pediatrics 1990;116(2):S55-9.
1989: Robert H Mak
Insulin secretion in uremia: effect of parathyroid hormone and vitamin D metabolites.
Kidney international. Supplement 1989;27():S227-30.
1989: Robert H Mak
Carbohydrate metabolism in uremia.
Pediatric nephrology (Berlin, Germany) 1989;3(2):201-8.
1988: C Turner; Juliet E Compston; Robert H Mak; Shobna Vedi; R W Mellish; George B Haycock; C Chantler
Bone turnover and 1,25-dihydroxycholecalciferol during treatment with phosphate binders.
Kidney international 1988;33(5):989-95.
1987: Robert H Mak; C Turner; T Thompson; George B Haycock; C Chantler
Glucose metabolism in children with uremia: effect of dietary phosphate and protein.
Kidney international. Supplement 1987;22():206-9.
1987: K Tamanaha; Robert H Mak; S P Rigden; C Turner; K M Start; George B Haycock; C Chantler
Long-term suppression of hyperparathyroidism by phosphate binders in uremic children.
Pediatric nephrology (Berlin, Germany) 1987;1(2):145-9.
1986: Robert H Mak; C Turner; T Thompson; George B Haycock; C Chantler
The effect of a low protein diet with amino acid/keto acid supplements on glucose metabolism in children with uremia.
The Journal of clinical endocrinology and metabolism 1986;63(4):985-9.
1985: Robert H Mak; C Turner; T Thompson; H Powell; George B Haycock; C Chantler
Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide.
British medical journal (Clinical research ed.) 1985;291(6496):623-7.
1985: Robert H Mak; A Bettinelli; C Turner; George B Haycock; C Chantler
The influence of hyperparathyroidism on glucose metabolism in uremia.
The Journal of clinical endocrinology and metabolism 1985;60(2):229-33.
1983: Robert H Mak; C Turner; George B Haycock; C Chantler
Secondary hyperparathyroidism and glucose intolerance in children with uremia.
Kidney international. Supplement 1983;16():S128-33.
1983: Robert H Mak; George B Haycock; C Chantler
Glucose intolerance in children with chronic renal failure.
Kidney international. Supplement 1983;15():S22-6.
1983: Robert H Mak; J Al Dahhan; D Azzopardi; M Bosque; C Chantler; George B Haycock
Measurement of glomerular filtration rate in children after renal transplantation.
Kidney international 1983;23(2):410-3.
1982: George B Haycock; J Al-Dahhan; Robert H Mak; C Chantler
Effect of indomethacin on clinical progress and renal function in cystinosis.
Archives of disease in childhood 1982;57(12):934-9.